FDA — authorised 16 March 2001
- Application: NDA021262
- Marketing authorisation holder: ABBVIE
- Local brand name: ALPHAGAN P
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
🇺🇸 Alphagan P in United States
FDA authorised Alphagan P on 16 March 2001
Marketing authorisations
FDA — authorised 19 August 2005
- Application: NDA021770
- Marketing authorisation holder: ABBVIE
- Local brand name: ALPHAGAN P
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
FDA
- Status: approved
Alphagan P in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Alphagan P approved in United States?
Yes. FDA authorised it on 16 March 2001; FDA authorised it on 19 August 2005; FDA has authorised it.
Who is the marketing authorisation holder for Alphagan P in United States?
ABBVIE holds the US marketing authorisation.